Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2022

Mar 7, 2022

31802_dirs_2022-03-07_572499c1-08cc-4e52-a729-a6e4c14db5e2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2022-03-03

Reporting Person: WHITE ROBERT S. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-03 Common Stock M 15000 $8.48 Acquired 37235 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-03 Non-qualified Stock Option (right to buy) $8.48 M 15000 Disposed 2023-03-11 Non-qualified Stock Option (right to buy) (15000.0) Direct

Footnotes

F1: These options were granted on March 11, 2013. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.